Zentalis Pharmaceuticals Announces $25 Million Equity Investment From Pfizer
Amount Raised
$25 Million
Round Type
Venture
San DiegoBiotechnologyHealthcareMedicalTherapeuticsPharmaceuticalresearchDescription
Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that it has agreed to sell 953,834 of its common shares at a price of $26.21 per share to Pfizer for gross proceeds of $25.0 million (the “Transaction”). The common shares were offered and sold to Pfizer in a registered direct offering conducted without an underwriter or placement agent. The offering is expected to close on or about April 29, 2022, subject to customary closing conditions
Quick answer
Zentalis Pharmaceuticals raised $25 Million in a funding round, dated April 27, 2022. Zentalis Pharmaceuticals is based in San Diego, California, United States.
- How much did Zentalis Pharmaceuticals raise?
- Zentalis Pharmaceuticals raised $25 Million in a funding round on April 27, 2022.
- What does Zentalis Pharmaceuticals do?
- Zentalis® Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant..
- Where is Zentalis Pharmaceuticals based and how big is it?
- Zentalis Pharmaceuticals is based in San Diego, California, United States. Fundz records about 170 employees.
- Who are the decision-makers at Zentalis Pharmaceuticals?
- Fundz holds 1 contact at Zentalis Pharmaceuticals, including the Vice President, Investor Relations and Corporate Communications. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Medical around the same time
Companies in the same sectors as Zentalis Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Biofrontera raised $9.4M on May 23, 2022.
- Rockwell Medical raised $15M (Funding Round) on June 7, 2022.
- Sanara MedTech raised $14M on June 2, 2022.
- Tempest Therapeutics raised $15M on May 11, 2022.
- INCOG BioPharma Services raised $15M on May 10, 2022.
- Treace raised $150M (Debt Financing) on May 2, 2022.
Who to call at Zentalis Pharmaceuticals, and when
A new round usually means Zentalis Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Zentalis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zentalis Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zentalis Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zentalis Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Zentalis Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.